COVID-19 mRNA vaccines.
J Genet Genomics
; 48(2): 107-114, 2021 02 20.
Article
in English
| MEDLINE | ID: covidwho-1316536
ABSTRACT
The ongoing COVID-19 pandemic and its unprecedented global societal and economic disruptive impact highlight the urgent need for safe and effective vaccines. Taking substantial advantages of versatility and rapid development, two mRNA vaccines against COVID-19 have completed late-stage clinical assessment at an unprecedented speed and reported positive results. In this review, we outline keynotes in mRNA vaccine development, discuss recently published data on COVID-19 mRNA vaccine candidates, focusing on those in clinical trials and analyze future potential challenges.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
RNA, Messenger
/
Vaccines, Synthetic
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Genet Genomics
Year:
2021
Document Type:
Article
Affiliation country:
J.jgg.2021.02.006
Similar
MEDLINE
...
LILACS
LIS